This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Cancer cell therapy, approved only for the very sick, depends on a complex and precisely...
Despite hitting the main goal of a mid-stage neuromuscular study, Acceleron isn't...
Analytics and CRO services firm IQVIA has kick-started a new matchmaking trial service...
Credit: Roberta Fulthorpe For most people, coffee is a necessary start to the day....
Credit: Augusta University Photography (Phil Jones) AUGUSTA, Ga. (May 8, 2020) –...
Credit: Photo courtesy of Northern Arizona University The global demand and consumption...
Immunocore has raised a $130 million (€117 million) series B round, ending its long...
Study indicates that distinct lipid mediators may offer new targets for more personalized...